Caina Technology Co., Ltd. (SHE:301122)

Market Cap	2.59B
Revenue (ttm)	349.97M
Net Income (ttm)	35.73M
Shares Out	122.25M
EPS (ttm)	0.29
PE Ratio	73.61
Forward PE	34.72
Dividend	0.25 (1.18%)
Ex-Dividend Date	May 30, 2025

Volume	2,520,650
Average Volume	1,713,448
Open	19.98
Previous Close	21.18
Day's Range	19.98 - 21.78
52-Week Range	14.61 - 26.10
Beta	0.62
RSI	57.36
Earnings Date	Aug 25, 2025

About Caina Technology

Caina Technology Co., Ltd. engages in the research, development, production, and sale of injection needles, syringes and other related medical devices. It offers disposable sterile safe self-destructing syringes, disposable insulin syringes, disposable sterile insulin pen needles, disposable sterile blood collection needles, and other sterile medical devices. Caina Technology Co., Ltd. was founded in 2004 and is based in Jiangyin, China.

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2004
• Employees: 783
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 301122

Financial Performance

In 2024, Caina Technology's revenue was 387.89 million, a decrease of -5.50% compared to the previous year's 410.47 million. Earnings were 53.09 million, a decrease of -52.83%.